Article

Modulation of hepatic mRNA-miRNA panel linked to NAFLD/NASH Hippo signaling and gut microbiota after administration of kefir in Non-Alcoholic Steatohepatitis Rat Model

2021-12-06

Abstract excerpt

<title>Abstract</title> <p>Non-alcoholic steatohepatitis (NASH) is the clinically aggressive variant of non-alcoholic fatty liver disease. Hippo pathway dysregulation can contribute to NASH development and progression. The use of probiotics is effective in NASH management. Our aim is to investigate the efficacy of kefir Milk in NASH management via modulation of hepatic mRNA-miRNA based panel linked to NAFLD/NASH...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7473e662-a571-5e00-9384-5b4da117f992
DOI: 10.21203/rs.3.rs-1138418/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Modulation of hepatic mRNA-miRNA panel linked to NAFLD/NASH Hippo signaling and gut microbiota after administration of kefir in Non-Alcoholic Steatohepatitis Rat ModelDOI 10.21203/rs.3.rs-1138418/v1Read

Probiotic-prebiotic-synbiotic modulation of (YAP1, LATS1 and NF2 mRNAs/miR-1205/lncRNA SRD5A3-AS1) panel in NASH animal modelSemantic proximity Read

mRNA-miRNA-lncRNA Regulatory Network in Nonalcoholic Fatty Liver DiseaseSemantic proximity Read

Integrated Bioinformatics Analysis Reveals Potential Mechanisms Associated with Intestinal Flora Intervention in Non-alcoholic Fatty Liver DiseaseSemantic proximity Read

Bridging the Gut and Liver: Multi-biotics modulate microbiota composition and corroborate transcriptomic improvements in MASLDSemantic proximity Read

Identification of biomarkers associated with immune-propionate metabolism in nonalcoholic fatty liver diseaseSemantic proximity Read

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment OptionsSemantic proximity Read

Identification of key target genes and pathway analysis in nonalcoholic fatty liver disease via integrated bioinformatics analysisSemantic proximity Read

Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver DiseaseSemantic proximity Read

Comprehensive analysis of endoplasmic reticulum-related and secretome gene expression profiles in the progression of non-alcoholic fatty liver diseaseSemantic proximity Read

Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and ChallengesSemantic proximity Read

Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severitySemantic proximity Read

Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH)Semantic proximity Read